v3.26.3
Accounts Payable and Accrued Expenses (Details Narrative) - USD ($)
Sep. 30, 2026
Dec. 31, 2025
Consideration payable $ 1,058,546
Accrued compensation 528,616 1,397,357
Employment Agreements [Member]    
Accrued compensation 528,616 $ 1,397,357
Pharm Ala Biotech Holdings Inc. [Member]    
Consideration payable $ 1,058,546